FindMyRecallSubscribe
Class I: serious health riskTerminated

Pharmakon Pharmaceuticals Midazolam 0 Recall

Midazolam 0

Pharmakon Pharmaceuticals · Noblesville, IN

Risk level
Class I
Reported by FDA
Jun 18, 2014
Recall ID
D-1362-2014
Check your lot numberHow we source this data

Summary

Pharmakon Pharmaceuticals recalled Midazolam 0 starting Mar 26, 2014. The FDA classified it as Class I (serious health risk) and published enforcement report D-1362-2014 on Jun 18, 2014. Reason: Superpotent Drug: Product contains twice the stated amount of midazolam. Status: Terminated.

Why it was recalled

Superpotent Drug: Product contains twice the stated amount of midazolam.

Product description

Midazolam 0.2 mg/2 mL 0.9% Sodium Chloride syringes, Total dosage: 0.4 mg per 2 mL, Rx Only, Pharmakon Pharmaceuticals, Inc., 14450 Getz Rd, Noblesville, Indiana, NDC 45183-0014-69.

Lot numbers, UPCs & expiration codes

Lot #: E1016227C, Exp. 4/21/2014; E0433735C, Exp. 4/20/2014

Where it was sold

IN

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1362-2014
Classification
Class I
Status
Terminated
Recall initiated
Mar 26, 2014
FDA report date
Jun 18, 2014
Quantity
80 syringes
Recall type
Voluntary: Firm initiated
Recalling firm
Pharmakon Pharmaceuticals

Original FDA data

Every field from FDA enforcement report D-1362-2014, exactly as published.

Show all FDA fields
City
Noblesville
State
IN
Status
Terminated
Country
United States
Event ID
67903
Address
14450 Getz Rd
Code information
Lot #: E1016227C, Exp. 4/21/2014; E0433735C, Exp. 4/20/2014
Postal code
46060-3303
Report date
Jun 18, 2014
Product type
Drugs
Recall number
D-1362-2014
Classification
Class I
Recalling firm
Pharmakon Pharmaceuticals
Product quantity
80 syringes
Termination date
Jul 31, 2014
Reason for recall
Superpotent Drug: Product contains twice the stated amount of midazolam.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Midazolam 0.2 mg/2 mL 0.9% Sodium Chloride syringes, Total dosage: 0.4 mg per 2 mL, Rx Only, Pharmakon Pharmaceuticals, Inc., 14450 Getz Rd, Noblesville, Indiana, NDC 45183-0014-69.
Distribution pattern
IN
Recall initiation date
Mar 26, 2014
Initial firm notification
Telephone
Center classification date
Jun 9, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1362-2014, published Jun 18, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls